Blutree Orthopedic Implants
Blutree Orthopedic Implants
Founded in 1999, our enterprise stands as one of the earliest research-driven manufacturing powerhouses in China dedicated to the R&D, formulation engineering, and precision production of medical-grade orthopedic cements, total joint prostheses, and trauma reconstruction systems. With state-of-the-art cleanroom manufacturing and over two decades of biomaterial innovations, we export medical devices and white-label OEM orthopedic solutions to over 160 countries and regions worldwide.
Engineered for seamless integration with high-viscosity PMMA bone cements in joint reconstruction and trauma fixation.
An authoritative analysis of exothermic polymerization, radiopacifier stabilization, and antibiotic-eluting pharmacokinetics.
Modern acrylic bone cements rely on a two-component system: a liquid monomer (Methyl Methacrylate, MMA) and a pre-polymerized powder (Polymethyl Methacrylate, PMMA). Upon mixing in the presence of Benzoyl Peroxide (BPO) initiator and N,N-Dimethyl-p-toluidine accelerator, a dynamic free-radical polymerization reaction ensues.
Surgeons require continuous fluoroscopic clarity during cement injection into the femoral canal or vertebral body. Simultaneously, prophylactic localized antibiotic delivery is imperative for preventing Periprosthetic Joint Infections (PJI).
| Property Parameter | ISO 5833 Standard Limit | Low Viscosity (Kyphoplasty Grade) | High Viscosity (Joint Arthroplasty Grade) |
|---|---|---|---|
| Compressive Strength | ≥ 70 MPa | 88 – 95 MPa | 92 – 105 MPa |
| Flexural Modulus | ≥ 1800 MPa | 2450 – 2700 MPa | 2800 – 3200 MPa |
| Flexural Strength | ≥ 50 MPa | 58 – 64 MPa | 65 – 72 MPa |
| Maximum Polymerization Temp | ≤ 90 °C | 74 °C – 78 °C | 78 °C – 82 °C |
| Doughing Time (at 23°C) | ≤ 5.0 min | 6.5 – 8.0 min (Extended injection window) | 2.0 – 3.5 min (Rapid initial handling) |
| Intrusion / Penetration Depth | ≥ 2.0 mm | 4.5 – 6.0 mm | 3.0 – 4.2 mm |
As a specialized OEM/ODM exporter, our laboratories formulate custom bone cement viscosity curves tailor-made for clinical requirements. Whether your commercial market demands a Low-Viscosity system with extended liquid phase for percutaneous vertebroplasty (PVP), or a High-Viscosity dough designed for immediate syringe application in total knee replacement (TKR), our team delivers validated formulations aligned with ISO 5833 standards.
End-to-end supply chain integration, automated cleanroom packaging, and high-precision testing machinery.
Seamless cross-border supply chains designed for multinational orthopedics brands, hospital distributors, and government tenders.
With 214 CE certificates and over 60 national registration approvals, our regulatory affairs team streamlines market entry into the EU (MDR 2017/745), US (FDA 510k), Latin America (ANVISA), and Southeast Asia (HSA/TGA).
Tailored PMMA matrix development for specialized delivery systems. We formulate custom liquid monomer ampoules (glass or aluminum) and powder sachets engineered specifically for manual mixing, pre-filled vacuum systems, or syringe injection.
Operating 3+ global logistics and technical hubs across the United States and Europe, we maintain safety buffer stock, ensuring guaranteed lead times and seamless contingency logistics for urgent surgical procurement.
Pioneering bioactive, osteo-conductive, and self-healing orthopedic cement formulations for tomorrow’s surgical demands.
Traditional PMMA acts primarily as an inert bio-mechanical grout. Our next-generation R&D roadmap focuses on incorporating micro-porous Bioactive Glass (45S5 nanospheres) and Hydroxyapatite (HA) matrix additives. These active inorganic compounds release $Ca^{2+}$ and $PO_4^{3-}$ ions upon contact with physiological fluids, facilitating direct biological osteointegration with cancellous bone trabeculae and reducing long-term implant aseptic loosening.
To counter the rising threat of multi-drug resistant (MDR) bacterial biofilms (such as MRSA and MRSE), our biomaterial scientists are developing dual-phase delivery mechanisms combining standard Gentamicin with synthetic cationic antimicrobial peptides (AMPs) and silver nanoparticles ($AgNP$). This dual-action release profile eradicates initial bacterial colonization without compromising the long-term compressive mechanical fatigue threshold of the cured cement.
Explore our full spectrum of trauma, maxillofacial, and intramedullary spinal/joint fixation products.
Clear answers to procurement, formulation engineering, quality standards, and export logistics queries.
